Posted inBiotechnology
Viridian’s other rival to Amgen’s Tepezza scores phase 3 win, but investors need convincing
Not content with lining up one potential rival to Amgen’s Tepezza, Viridian Therapeutics has scored a phase 3 win for…
Posted inGenetics
African Trypanosomes Use a Molecular Shredder to Avoid Detection in the Bloodstream
In mammalian hosts, the African trypanosome parasite replicates freely in the bloodstream, despite being fully exposed to the immune system.…
Posted inBiotechnology
Genetic Link Between Schizophrenia and Obesity Revealed
The Intricate Genetic Links Between Schizophrenia and Obesity: Unraveling a Neuropsychiatric Enigma Recent groundbreaking research published in the International Journal…
Posted inBiotechnology
Eligibility Criteria for Pediatric ER Redirection: Insights
In a landscape where pediatric emergency departments (EDs) are increasingly overwhelmed, healthcare systems worldwide grapple with the dual challenge of…
Posted inBiotechnology
ECG Practices in Elderly Patients: Quaternary Hospital Study
In the evolving landscape of cardiovascular diagnostics, a new study published in BMC Geriatrics in 2026 offers unprecedented insights into…
Posted inBiotechnology
Innovative VIKOR-AHP Method Advances Green Energy Decisions
In a groundbreaking advancement poised to transform the landscape of sustainable energy deployment, researchers have unveiled an innovative decision-making framework…
Posted inBiotechnology
MAU2 Mutations Define Unique Cornelia de Lange Syndrome
In a groundbreaking study poised to redefine our understanding of rare genetic disorders, researchers have identified pathogenic variants in the…
Posted inBiotechnology
Designable Vectorial Lasing via Möbius-Like Quasi-BICs
A recent breakthrough in the field of photonics has captured the attention of researchers and technologists worldwide. The pioneering work…
Posted inBiotechnology
Holistic Strategy in New Brain-Heart Guidelines Revolutionizes Chronic Disease Management
A groundbreaking clinical practice guideline has been unveiled that addresses the intricate and interdependent relationship between brain and heart diseases,…
Posted inBiotechnology
Kardigan hypertension drug tangles biomarker win with blood pressure miss in phase 2 trial
Kardigan’s tonlamarsen reduced a key biomarker for hypertension in a phase 2 trial, but missed the study’s other goal of…